Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Road to elimination of HCV: Clinical challenges in HCV management.

Liver international : official journal of the International Association for the Study of the Liver - 1 Aug 2022

Hayes C Nelson, Imamura Michio, Tanaka Junko, Chayama Kazuaki

Abstract excerpt

Since its discovery in 1989, the road to a cure for hepatitis C virus (HCV) has been slow, but most patients can now expect to achieve a sustained virological response (SVR). With direct-acting antiviral (DAA) combination therapies such as glecaprevir/pibrentasvir and velpatasvir/sofosbuvir, 98% of patients successfully eradicate the virus, even if previous treatments failed or if resistance-associated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Sofosbuvir
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to Hepatitis C

Share to Hepatitis C, Chronic

Share to Homosexuality, Male

Share to Sexual and Gender Minorities

Source

Identifiers

PMID: 34967486
DOI: 10.1111/liv.15150

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Road to elimination of HCV: Clinical challenges in HCV management.PMID 34967486Read ↗

Hepatitis C virus elimination: So close, so far?Semantic proximity Read ↗

The eradication of HCV.Semantic proximity Read ↗

HCV management in resource-constrained countries.Semantic proximity Read ↗

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV eliminationSemantic proximity Read ↗

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study.Semantic proximity Read ↗

Like a Rolling Stone? A Review on Spontaneous Clearance of Hepatitis C Virus Infection.Semantic proximity Read ↗

Therapy of hepatitis C: from empiricism to eradication.Semantic proximity Read ↗

Heading Toward the Elimination of Hepatitis C Virus.Semantic proximity Read ↗

Into the light: strategies for battling hepatitis C.Semantic proximity Read ↗

Management of direct antiviral agent failures.Semantic proximity Read ↗

Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection.Semantic proximity Read ↗

Cost effectiveness of hepatitis C direct acting agents.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.